Antiretroviral Therapy News
- The Changing Brain Signature of HIV
- Many Health Plans Must Cover Full Cost of HIV Prevention Drugs
- Vaginal Microbiota Can Affect HIV PrEP Drug Metabolism
- Drug Combo Injection Every 8 Weeks Safe, Effective in HIV: Study
- HIV Generic Drug for Babies to Be Rolled Out in Africa in 2021: Aid Agencies
- Many Title X Clinics in Southern US Refer Young Women Elsewhere for PrEP
- IDSA Updates COVID Guidelines for Antibodies, Antivirals, Others
- ANAC 2020 HIV PrEP Prescriptions Often Go Unfilled
- ANAC 2020 Escalate HIV Adherence Strategies Amid COVID-19
- IDWeek 2020 Aging With HIV Adds to Comorbidity Burden
- USCA 2020 HIV PrEP Referrals Lag for Black MSM, Trans Adults
- IDWeek 2020 Shared Decision-Making Aids Choice of PrEP
- USCA 2020 Holistic Care, Universal First-Line HIV ART Speed Care
- IDWeek 2020 TDF Preferred in PrEP for Blacks and Women, Studies Indicate
- Integrase Strand Transfer Inhibitors Unlikely to Cause Birth Defects in HIV-Positive Pregnant Women
- USCA 2020 HIV Testing Meets COVID-19, and the News Isn't All Bad
- HIV Drugs Prevent Type 2 Diabetes, May Be Path to New Therapy
- HIV Glasgow 2020 Four-Week, 8-Week CAB/RPV Injections Safe, Effective in Women
- HIV Glasgow 2020 Heterosexual Men Likely to Have Unmet HIV Treatment Needs
- HIV Glasgow 2020 Being HIV Positive Increases Risk of Death From COVID-19
- HIV Glasgow 2020 Switch to Integrase Inhibitor Regimen Safe and Effective